1. Bioorg Med Chem Lett. 2005 Aug 15;15(16):3701-6. doi: 
10.1016/j.bmcl.2005.05.130.

1-(4-Amino-phenyl)-pyrrolidin-3-yl-amine and 
6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine derivatives as 
melanin-concentrating hormone receptor-1 antagonists.

Huang CQ(1), Baker T, Schwarz D, Fan J, Heise CE, Zhang M, Goodfellow VS, 
Markison S, Gogas KR, Chen T, Wang XC, Zhu YF.

Author information:
(1)Department of Medicinal Chemistry, Neurocrine Biosciences, Inc., 12790 El 
Camino Real, San Diego, CA 92130, USA.

Derivatives of 1-(4-amino-phenyl)-pyrrolidin-3-yl-amine and 
6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine were identified as potent and 
functionally active MCH-R1 antagonists. One compound with Ki = 2.3 nM 
demonstrated good oral bioavailability (32%) and in vivo efficacy in rats.

DOI: 10.1016/j.bmcl.2005.05.130
PMID: 16005225 [Indexed for MEDLINE]
